Barclays PLC Precipio, Inc. Transaction History

Barclays PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$1.81 - $2.6 $22,263 - $31,980	-12,300 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.18 - $4.08 $34,662 - $64,872	-15,900 Reduced 56.38%	12,300 $32,000
Q2 2019 Aug 14, 2019	BUY	$1.89 - $9.15 $53,298 - $258,030	28,200 New	28,200 $96,000

340

Ticker PRPO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 22,736,500
Market Cap $143M
Description
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust geneti...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.